Wiltrom Co

Wiltrom Co Net Debt per Share

The Net Debt per Share of Wiltrom Co (6767.TWO) as of Nov 3, 2026 is 1.67 TWD. In the previous year, Net Debt per Share was 1.43 TWD — a change of 17.07% (higher).

Net Debt per Share

1.67TWD

YoY

17.07%

Last updated:

Net Debt per Share of Wiltrom Co is 2025 1.67 TWD. Net Debt per Share of Wiltrom Co was 2024 1.43 TWD. It decreases by 17.07% higher compared to the previous year.

The Wiltrom Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
-1.10 TWD
Jan 1, 2019
-3.32 TWD
Jan 1, 2020
-3.23 TWD
Jan 1, 2021
1.15 TWD
Jan 1, 2022
1.62 TWD
Jan 1, 2023
1.51 TWD
Jan 1, 2024
1.43 TWD
Jan 1, 2025
1.67 TWD
The Wiltrom Co Net Debt per Share history
YEARNet Debt per ShareYoY
1.67TWD+17.07%
1.43TWD-5.25%
1.51TWD-6.95%
1.62TWD+40.74%
1.15TWD-135.57%
-3.23TWD-2.57%
-3.32TWD+201.94%
-1.10TWD-31.02%
-1.59TWD-40.87%
-2.69TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wiltrom Co Stock analysis

What does Wiltrom Co do? Wiltrom Co., Ltd. generates revenue through the research, production, and distribution of high-end medical devices, including spinal fixators, artificial bones, and interbody fusion cages. The company focuses on Class II and Class III implantable devices, targeting spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. Its primary markets are Taiwan, Asia, and America, where it sells directly to hospitals and medical institutions. The firm's product portfolio is designed for specialized surgical procedures, with spinal fusion surgery products forming a core segment of its business. The company's revenue streams are derived from the sale of spinal fixators, artificial bones, and interbody fusion cages, which are categorized under spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. These products are distributed across Taiwan, Asia, and America, with a strong emphasis on the spinal fusion surgery market. Wiltrom's focus on high-end, implantable Class II and Class III medical devices ensures a premium pricing strategy, aligning with the specialized needs of surgical procedures. Wiltrom Co., Ltd. serves healthcare providers in Taiwan, Asia, and America, delivering Class II and Class III medical devices for spinal fusion, spinal compression fracture, and bone cement applications. The company's products are tailored to specific surgical segments, with spinal fusion surgery products representing a significant portion of its sales. Revenue is generated through direct sales to hospitals and medical institutions within its key geographic markets. Wiltrom Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wiltrom Co stock

Net Debt per Share of Wiltrom Co is 1.67 TWD in 2025.

Net Debt per Share of Wiltrom Co changed from 1.43 TWD to 1.67 TWD, representing a 17.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Wiltrom Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Wiltrom Co

All Key Metrics — Wiltrom Co